Jynarque
Ended Awarded
- Contract number
- 36C24622N0763
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $137,193
Award facts
- Contract value 100% obligated
- $137,192.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc., a pharmaceutical manufacturer headquartered in Rockville, Maryland, received a delivery order award from the Department of Veterans Affairs' Veterans Integrated Service Network 6 on June 23, 2022, for the supply of Jynarque (tolvaptan). This firm-fixed price delivery order has a ceiling value of approximately $137K and is scheduled for completion by September 30, 2022. The award represents performance under the parent GSA Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB) and does not utilize any set-aside designation. The product will be delivered to Pittsburgh, Pennsylvania, supporting the VA's mission to provide specialized pharmaceutical treatments to veterans.
This delivery order falls under a larger Indefinite Delivery Vehicle structure, specifically a Blanket Purchase Agreement valued at approximately $83.3 million through the National Acquisition Center with a completion date of March 26, 2026. Jynarque is a specialized medication used to treat autosomal dominant polycystic kidney disease and hyponatremia, and this delivery order enables Veterans Integrated Service Network 6 to efficiently procure the medication through established procurement channels. Otsuka America Pharmaceutical Inc. maintains significant federal supply agreements with the VA across multiple Integrated Service Networks, reflecting its established capability as a large pharmaceutical manufacturer to support the Veterans Health Administration's comprehensive healthcare services.
Quick answers
Who was awarded contract 36C24622N0763?
36C24622N0763 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on June 23, 2022.
How much is contract 36C24622N0763 worth?
The government has obligated $137,193 on 36C24622N0763.
Is contract 36C24622N0763 an order under another contract?
Yes. 36C24622N0763 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24622N0763 competed?
The extent of competition for 36C24622N0763 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award